ASTRAZENECA PLC (AZN) Form 6-K — Sep 1, 2026
AstraZeneca PLC announced on 1 September 2026 that Wan Ling Martello has been appointed as a Non-Executive Director with immediate effect, joining the Board's Audit Committee on appointment. Martello is a former Nestlé global CFO who later led Nestlé's Asia, Oceania and Sub-Saharan Africa business, and currently serves as a founding partner of Boston-based private equity firm BayPine, an Independent Director of Alibaba Group, and a Director of The Lovesac Company, with prior board seats at Uber Technologies and Stellantis. AstraZeneca Chair Michel Demaré said her CFO and digital transformation experience will significantly benefit her Audit Committee work.
Key figures
- Prior Board Uber
- June 2017 to May 2025
- Joins Audit Committee
- Yes
- Prior Board Stellantis
- January 2021 to April 2025
- Appointment Effective Date
- 1 September 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.